Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609180 · ClinicalTrials.gov registry record · Phase 3
Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)
A Phase 3 study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Terminated
- Registry status
- Phase 3
- Development phase
- 272
- Enrollment target
NCT00609180 is a Phase 3 study that was terminated before completion, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 272 participants.
The verdict
NCT00609180, a Phase 3 study, was terminated before completion, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 272 participants
- Enrollment target
Study Summary
Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) are medical conditions that occur when there is severe inflammation and increased fluids in both lungs, making it difficult for the lungs to function properly. Hospital treatment for a person with ALI/ARDS often includes the use of a breathing machine, or ventilator, until the person is able to breathe without assistance. Initiating proper nutrition through a feeding tube early in a person's hospital stay may help to improve recovery, but the optimal timing, composition, and amount of feeding treatments are unknown. This study will evaluate whether early or delayed full-calorie feeding through a feeding tube is more effective in reducing recovery time and increasing survival rates in people with ALI/ARDS. The study will also determine whether supplementing the feedings with omega-3 fatty acids and antioxidants benefits people with ALI/ARDS.
Interventions
- DIETARY_SUPPLEMENT Placebo
- BEHAVIORAL Minimal (Trophic) Feeding
- BEHAVIORAL Full Feeding
- DIETARY_SUPPLEMENT Omega-3 Fatty Acids and Antioxidant Supplements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00609180
The ClinicalTrials.gov registry entry for NCT00609180 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00609180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00609180 about?
NCT00609180 is a clinical study titled "Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)". Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) are medical conditions that occur when there is severe inflammation and increased fluids in both lungs, making it difficult for the lungs to function properly. Hospital treatment for a person with ALI/ARDS often includes the use ...
What is the current status of trial NCT00609180?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 272 participants. The study started on 2007-12. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00609180?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Minimal (Trophic) Feeding (BEHAVIORAL), Full Feeding (BEHAVIORAL), Omega-3 Fatty Acids and Antioxidant Supplements (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00609180?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.